ChartRow logo
Share this page
TVTX
$49.60-6.04%
as of close, Oct 16, 2026
☾ AH $49.60 -6.04%
PeersMRNALLYMDTUNHJNJTMO

Travere Therapeutics Inc. trailing returns

Travere Therapeutics Inc.'s 10-year return is +8.8% a year (CAGR) (+132.4% cumulative). How Travere Therapeutics Inc. (TVTX) has performed over the last day, week, month and year, over 5 and 10 years, and since inception, through October 16, 2026 — price return and dividends side by side, with the worst drop inside each window.

Trailing returns by period#

To 2026-10-16. Price return + dividends = total return. Per year (CAGR) for windows of a year or more, with the cumulative total return beneath. Worst drop: the deepest fall in the price from a high inside the window, and when it bottomed.

PeriodPriceDivsTotalWorst drop
1 day-6.0%+0.0%-6.0%—
5 days-4.8%+0.0%-4.8%-6.9%Oct 16
1 month-21.9%+0.0%-21.9%-23.4%Oct 16
YTD+29.8%+0.0%+29.8%-32.2%Mar 24
1 year+80.3%+0.0%+80.3%-33.5%Mar 2026
5 years+15.1%+0.0%+15.1%+102.4%-83.1%Apr 2024
10 years+8.8%+0.0%+8.8%+132.4%-83.6%Apr 2024
Since inception (2012)+25.9%+0.0%+25.9%+2367.7%-85.4%Apr 2024

Growth of TVTX#

Actual level with dividends reinvested (solid); dashed lines are each window's constant-rate path from start to today.

  • 5 years+15.1%/year · +102.4%
  • 10 years+8.8%/year · +132.4%

Methodology#

Trailing returns measure from the closest close about N years before the latest close (2026-10-16). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Price return is the change in TVTX's closing price; total return reinvests dividends (from its split- and dividend-adjusted closes); the dividends column is the difference between the two. The worst drop is the largest fall in the closing price from a high to a later low inside the window, the way a drawdown is usually quoted. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.

FAQ#

What is Travere Therapeutics Inc.'s 10-year return?
Over the last 10 years, Travere Therapeutics Inc. (TVTX) returned about +8.8% a year annualized (+132.4% cumulative total return).
What is Travere Therapeutics Inc.'s return since inception?
Since 2012, Travere Therapeutics Inc. (TVTX) has compounded at about +25.9% a year — +2367.7% in total.

More on Travere Therapeutics Inc.